allyl isothiocyanate has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; Chen, CS; Chen, YC; Hsu, YA; Huang, CC; Lin, CJ; Lin, CW; Lin, HJ; Liu, FT; Lo, CW; Wan, L | 1 |
| Kou, YR; Lee, TS; Lu, TM; Shyue, SK; Zhao, JF | 1 |
2 other study(ies) available for allyl isothiocyanate and Atherosclerosis
| Article | Year |
|---|---|
Allyl Isothiocyanate Ameliorates Obesity by Inhibiting Galectin-12.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Animals; Atherosclerosis; Cell Differentiation; Cyclic AMP Response Element-Binding Protein; Galectin 2; Isothiocyanates; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Obesity | 2018 |
Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blotting, Western; Cholesterol; Foam Cells; Immunohistochemistry; Isothiocyanates; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2016 |